当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:190.25亿  总市值:245.83亿
流通股本:7.63亿   总股本:9.86亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,474,934,030.73994,903,657.69493,939,610.73231,060,650.6
收到的税费返还143,929,288.86143,929,288.86129,854,553.65-
收到其他与经营活动有关的现金122,669,834.9997,647,401.24100,460,611.0370,941,440.48
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,741,533,154.581,236,480,347.79724,254,775.41302,002,091.08
购买商品、接受劳务支付的现金2,082,560,054.821,648,909,781.581,088,928,491.83562,535,881.61
支付给职工以及为职工支付的现金1,254,991,680.89958,338,967.96657,743,224.13368,099,077.26
支付的各项税费78,513,316.8558,013,895.3441,171,147.9824,156,643.63
支付其他与经营活动有关的现金330,450,198.99235,331,895.56162,133,712.5467,461,453.47
经营活动现金流出的平衡项目0000
经营活动现金流出小计3,746,515,251.552,900,594,540.441,949,976,576.481,022,253,055.97
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-2,004,982,096.97-1,664,114,192.65-1,225,721,801.07-720,250,964.89
二、投资活动产生的现金流量:
收回投资收到的现金1,246,870,799.381,205,410,678.811,202,852,598.61402,852,598.61
取得投资收益收到的现金4,234,520.554,234,520.554,234,520.551,766,575.34
处置固定资产、无形资产和其他长期资产收回的现金净额4,097,167.3422,123.8922,123.88-
收到的其他与投资活动有关的现金103,189,128.3381,168,910.7958,169,603.9628,148,356.36
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,358,391,615.61,290,836,234.041,265,278,847432,767,530.31
购建固定资产、无形资产和其他长期资产支付的现金832,574,528.57604,662,480.18201,430,071.66125,640,355.94
投资支付的现金1,459,007,993.151,340,008,0001,230,000,000800,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,291,582,521.721,944,670,480.181,431,430,071.66925,640,355.94
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-933,190,906.12-653,834,246.14-166,151,224.66-492,872,825.63
三、筹资活动产生的现金流量:
吸收投资收到的现金155,594,530.5155,594,530.5155,594,530.5155,594,530.5
其中:子公司吸收少数股东投资收到的现金3,000,0003,000,0003,000,0003,000,000
取得借款收到的现金977,095,079.63602,682,782.88214,726,408.6491,300,398.11
收到其他与筹资活动有关的现金207,889,063.78179,512,525.1241,299,690.391,672,821.58
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,340,578,673.91937,789,838.5411,620,629.53248,567,750.19
偿还债务支付的现金480,915,060.85389,228,852.72116,669,118.4315,000,000
分配股利、利润或偿付利息支付的现金38,226,802.1127,697,403.4717,998,153.668,786,415.73
支付其他与筹资活动有关的现金109,609,030.9979,669,279.6353,355,135.2813,328,173.76
筹资活动现金流出平衡项目0000
筹资活动现金流出小计628,750,893.95496,595,535.82188,022,407.3737,114,589.49
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额711,827,779.96441,194,302.68223,598,222.16211,453,160.7
四、汇率变动对现金及现金等价物的影响7,551,261.1821,536,381.0525,100,592.95-10,637,565.29
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-2,218,793,961.95-1,855,217,755.06-1,143,174,210.62-1,012,308,195.11
加:期初现金及现金等价物余额5,996,935,997.835,996,935,997.835,996,935,997.835,996,935,997.83
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,778,142,035.884,141,718,242.774,853,761,787.214,984,627,802.72
补充资料:
净利润-2,535,689,297.85--1,126,329,526.49-
资产减值准备126,313,501.28-36,357,648.87-
固定资产和投资性房地产折旧248,629,278.03-117,563,865.27-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧248,629,278.03-117,563,865.27-
无形资产摊销23,695,564.99-9,674,560.11-
长期待摊费用摊销17,116,437.55-8,343,984.39-
处置固定资产、无形资产和其他长期资产的损失-29,406,432.28--510,895.52-
固定资产报废损失520,267-341,239.65-
公允价值变动损失149,177,392.25-27,766,182.96-
财务费用-57,756,280.09--38,175,741.35-
投资损失-73,990,355.55-28,070,638.56-
递延所得税125,030,970.96-55,736,737.17-
其中:递延所得税资产减少125,030,970.96-55,736,737.17-
存货的减少-32,448,335.17--89,867,273.75-
经营性应收项目的减少-314,417,914.33--287,260,819.66-
经营性应付项目的增加262,671,653.75--8,933,202.26-
其他19,008,838.92-18,082,857.84-
现金的期末余额3,778,142,035.88-4,853,761,787.21-
减:现金的期初余额5,996,935,997.83-5,996,935,997.83-
公告日期2024-03-292023-10-282023-08-312023-04-29
审计意见(境内)标准无保留意见
TOP↑